Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its insiders. Immuneering Corp shares valued at $34,788 were purchased by Schall Thomas J. on Jun 27 ’25. At $3.66 per share, Schall Thomas J. acquired 9,500 shares. The insider’s holdings grew to 52,885 shares worth approximately $0.19 million following the completion of this transaction.
Also, Hall Brett Matthew purchased 7,415 shares, netting a total of over 20,020 in proceeds. Following the buying of shares at $2.70 each, the insider now holds 353,311 shares.
Before that, Hall Brett Matthew had added 6,007 shares to its account. In a trade valued at $14,596, the CHIEF SCIENTIFIC OFFICER bought Immuneering Corp shares for $2.43 each. Upon closing the transaction, the insider’s holdings increased to 6,007 shares, worth approximately $1.29 million.
As published in a research note from Morgan Stanley on December 13, 2024, Immuneering Corp [IMRX] has been rated down from an Equal-weight to an Underweight. Analysts at Needham resumed the stock at ‘”a Buy”‘ outlook in a report released in mid March. As of March 15, 2024, TD Cowen has decreased its “an Outperform” rating to a “Market perform” for IMRX. Earlier on March 15, 2024, Jefferies downgraded its rating. Their new recommendation was “a Hold” for IMRX stock which previously was a “a Buy”.
Analyzing IMRX Stock Performance
On last trading session,, Immuneering Corp [NASDAQ: IMRX] rose 4.36% to $3.59. The stock’s lowest price that day was $3.45, but it reached a high of $3.69 in the same session. During the last five days, there has been a surge of approximately 18.87%. Over the course of the year, Immuneering Corp shares have jumped approximately 180.47%. Shares of the company reached a 52-week high of $3.87 on 06/27/25 and a 52-week low of $1.10 on 05/12/25.
Support And Resistance Levels for Immuneering Corp (IMRX)
According to the 24-hour chart, there is a support level at 3.46, which, if violated, would cause prices to drop to 3.34. In the upper region, resistance lies at 3.70. The next price resistance is at 3.82. RSI (Relative Strength Index) is 71.57 on the 14-day chart, showing overbought technical sentiment.
Is Immuneering Corp subject to short interest?
Stocks of Immuneering Corp saw a sharp rise in short interest on 2025-06-13 jumping by 0.23 million shares to 0.89 million. Data from Yahoo Finance shows that the short interest on 2025-05-15 was 0.66 million shares. A jump of 26.07% in short interest reflects a negative sentiment towards the stock. Despite the fact that short shares comprise just 3.13 of the overall float, the days-to-cover ratio (short ratio) jumped to 3.13.
Which companies own the most shares of Immuneering Corp (IMRX)?
In terms of Immuneering Corp share price expectations, FactSet research, analysts set an average price target of 13 in the next 12 months, up nearly 277.91% from the previous closing price of $3.44. Analysts anticipate Immuneering Corp stock to reach 41 by 2025, with the lowest price target being 3. In spite of this, 3 analysts ranked Immuneering Corp stock as Buy at the end of 2025. On December 01, 2023, Needham assigned a price target of “a Buy” to the stock and initiated coverage with a $20.
